Composition for increasing pregnancy rate of ruminants and preparation method and application thereof
US-2022117940-A1 · Apr 21, 2022 · US
US11896580B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11896580-B2 |
| Application number | US-202117502735-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 15, 2021 |
| Priority date | Oct 16, 2020 |
| Publication date | Feb 13, 2024 |
| Grant date | Feb 13, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The disclosure discloses a composition containing melatonin as an effective ingredient, and its application in improving DHI production performance and improving milk quality. The composition containing melatonin as an effective ingredient according to the present disclosure can significantly reduce the somatic cell count in milk and improve milk quality. Under the conditions of different seasons, ages, and lactation periods, the administration of the composition containing melatonin as an active ingredient according to the present disclosure can significantly reduce the somatic cell score of cow milk (p<0.01), increase the protein content and lactose content in milk, and meanwhile reduce the fat content and urea nitrogen content in milk. In summary, the composition containing melatonin as an effective ingredient according to the present disclosure can improve the quality of milk and increase the efficiency of dairy cow breeding.
Opening claim text (preview).
What is claimed is: 1. A composition for improving milk quality of a dairy cow, comprising melatonin as an active ingredient, absolute ethanol and physiological saline; wherein the concentration of melatonin in the composition is of 1 to 20 mg/mL, and the volume ratio of absolute ethanol to physiological saline is in a range of (1-3):(1-2). 2. The composition according to claim 1 , wherein the volume ratio of absolute ethanol to physiological saline is 3:2. 3. A method for preparing the composition of claim 1 , comprising the following steps: dissolving melatonin in absolute ethanol and then adding physiological saline, wherein the steps are carried out in dark, the concentration of melatonin in the composition is of 1 to 20 mg/ml, and the volume ratio of absolute ethanol to physiological saline is in a range of (1-3):(1-2). 4. The method according to claim 3 , wherein the volume ratio of absolute ethanol to physiological saline is 3:2.
Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin · CPC title
for lactation disorders, e.g. galactorrhoea · CPC title
Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00) · CPC title
Solutions {(composition of solutions A61K47/00)} · CPC title
Inorganic compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.